The “Let's talk with VCs! vol.11 Discover Houston: A Thriving Hub for Life Science Innovation” was held in a virtual format on Wednesday, December 18, 2024. (Organizer: LINK-J)
The recording is available on LINK-J's YouTube channel.
[Click on the image to play the recording]
Overview
The Texas Medical Center (TMC), renowned as the world's largest medical center, is distinguished by its scale and scientific rigor. Located in Houston, Texas, this medical city comprises over 54 medical institutions, 21 hospitals, 8 research institutions, and 4 medical universities. Approximately 106,000 medical professionals and researchers are active daily, and over 10 million patient visits are conducted annually.
TMC is home to renowned medical institutions such as the MD Anderson Cancer Center, a leader in cancer treatment in the world. Additionally, there is a strong integration of medical care and research within the academic institutions, including the University of Texas Health Science Center and Baylor College of Medicine, enabling a smooth translation from basic research to clinical applications. TMC institutions consistently collaborate with industry partners globally. Houston is home to numerous life science incubators and accelerators, offering a comprehensive range of resources including lab and office space, access to medical and scientific talent, KOLs, CROs, CMOs, investors, grants, and a wide array of networking opportunities.
Compared to cities like Boston and San Francisco, Houston offers a lower cost of living and business expenses. Additionally, Texas has long upheld a business-friendly environment, with favorable taxation and regulations, making it an appealing choice for startups. However, the Japanese life science community remains largely unaware of the valuable resources Houston provides. As Japan’s life science ventures increasingly seek U.S. opportunities for business development and clinical trials, Houston should be considered a viable option for establishing operations.
For Japan’s biopharmaceutical and medical technology community, collaborating or investing with the Houston medical community provides access to cutting-edge technology, opportunities for joint research and clinical trials in the U.S., and the ability to build global partnerships while expanding commercialization efforts into the U.S. Conversely, there are significant business opportunities for introducing Houston-developed technologies and products to Japan.
We are excited to explore these possibilities for innovation and commercial growth, as we work to connect global technology hubs and create a truly global life science ecosystem.
Speakers
Emily Reiser, Ph.D., Director, Strategy and New Ventures, Texas Medical Center (TMC)
Allison Rhines, Ph.D., Site Head, JLABS at Texas Medical Center (TMC)
Paul Wotton, Ph.D., CEO RBL LLC and Chair Rice Biotech LaunchPad
Fred Shane, CEO, Axil Capital Advisors K.K.
Introduction
Mr. Fred Shane
Presentations
“Overview of Houston as an Innovation Hub”
“Introducing Texas Medical Center Innovation (TMCi)”
Emily Reiser, Ph.D.
"Introducing JLABS@TMC”
Allison Rhines, Ph.D.
[Overview]
Johnson & Johnson Innovation – JLABS (JLABS) is a global incubator network that provides early-stage innovators with access to capital-efficient lab space, equipment and resources, including expertise, community, industry connections and entrepreneurial programs. Our goal is to accelerate life science and health technology innovations to the people who need them.
“Introducing RBL LLC”
Paul Wotton, Ph.D.
Panel Discussion
.png)
Moderator: Mr. Fred Shane
Panelists: Dr. Paul Wotton, Dr. Emily Reiser, Dr. Allison Rhines
They discussed the following topics, answering questions from the audience.
- What leading institutions and resources are available in Houston's medical center, and what types of technologies or products are suitable for entrepreneurs to leverage these resources?"
- What are some common pitfalls for foreign companies attempting to leverage Houston’s resources? What are some typical mistakes that you have seen in the past?
- What would you hope to gain from connecting with the Japanese life science players?
- How can an entrepreneur or investor begin exploring opportunities in Houston?
Closing Remarks
The webinar concluded with closing remarks by LINK-J General Manager, Ikuo Hayashi.
Thank you very much for your participation.
